X

RECEIVE OUR NEWSLETTER

NEWS FOR DENTISTRY PROFESSIONALS
News

PERIO·AID. THE CHOICE IS YOURS IN EVERY SITUATION

11th October 2016 0
Share this

The Perio·Aid® range has updated its image in order to differentiate the range of products that comprises it.

The official presentation of the new Perio·Aid® image took place at the 50th Meeting of the Spanish Society of Periodontology and Osseointegration (SEPA) held in Valencia.

Perio·Aid® is the oral antiseptic indicated for periodontal and peri-implant disease treatment and maintenance.

Its unique formulation, containing the combination of two antiseptics, Chlorhexidine (CHX) and Cetylpyridinium Chloride (CPC), obtains maximum efficacy in the treatment and control of periodontal and peri-plant diseases.

Perio·Aid® presents two different concentrations that guarantee the best solution in every situation. 

THE UNIQUE FORMULATION OF PERIO·AID® IS BASED ON A COMBINATION OF TWO ANTISEPTICS: CHLORHEXIDINE AND CETYLPYRIDINIUM CHLORIDE

WHEN CARE IS NEEDED

Perio·Aid® 0.12 Treatment. (CHX 0.12% + CPC 0.05%)

  • Used for active infections, it helps to TREAT periodontal and/or peri-implant disease, as it assists in the elimination of the pathogenic biofilm that causes these diseases.
  • Available in various forms according to use and indication:
- Mouthwash. Controls bacterial load after toothbrushing. Rinsing is recommended twice daily, as chlorhexidine is released gradually, with a substantivity of 12 hours.
- Gel. Formulation used for application as a dental gel with a toothbrush, and as a topical gel for application with gauze or a clean finger in areas requiring antiseptic protection.
Spray. Especially indicated for hard-to-reach areas (for example the rear of the oral cavity) or for those who cannot properly use mouthwash.

WHEN CONTROL IS NEEDED

Perio·Aid® 0.05 Maintenance and Control. (CHX 0.05%+ CPC 0.05%)

  • Helps keep pathogenic biofilm UNDER CONTROL daily.
  • Its formulation, with low-concentration CHX plus CPC, is scientifically proven to have the same efficacy as formulations containing higher concentrations (CHX 0.12%).
  • May be used long term with minimal side effects.
  • Especially indicated for maintenance to prevent the development of periodontal and peri-implant diseases in patients at risk:
- Diabetics with inflamed and bleeding gums.
- Those with cardiovascular disease and gum problems.
Those at risk of infection: immunocompromised patients, patients being treated with chemotherapy and/or radiation therapy, etc.
 
Comments
MOST WATCHEDMOST COMMENTED

DENTAIDEXPERTISE © 2019

Contact - Privacy Policy - Cookies Policy